Evidence map›Paper›PMID 42754237›Full record

ArticleClinical medicine (London, England)2026

'So it's real': Fibromyalgia, diagnostic injustice, and the case for a shared system response.

Surabhi Wig

Abstract read
In one paragraph

Article in Clinical medicine (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Surabhi WigDepartment of Rheumatology, Bolton NHS Trust, Bolton BL35BN, United Kingdom; University of Greater Manchester, United Kingdom. Electronic address: surabhi.wig@boltonft.nhs.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fibromyalgia affects 2-4.5% of the UK population, yet remains among the most poorly recognised and inequitably managed conditions in primary and secondary care. Diagnostic delay averages six years with direct clinical and economic consequences, compounded by persistent stigma rooted in historical scepticism of patients' symptomatology. Recent guidance from the RCP, BSR, GIRFT, and NICE has sought to improve diagnostic clarity and management pathways, yet implementation remains inconsistent and fragmented across England. Current referral arrangements and service provision create institutional barriers that fall disproportionately on patients in deprived areas. This paper examines these systemic failures and argues for a coordinated, multi-level response spanning diagnostic confidence in primary care, specialist consultation as a clinical intervention, equitable access to pain services, and workforce training reform. The goal is not specialist ownership, but integrated contribution from every part of the healthcare pathway.

Indexed as

Central sensitisationDiagnostic delayFibromyalgiaHealth inequalitiesNociplastic painPrimary care

Identifiers

PMID42754237
PMCPMC13653932

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.